Search

everythinglearnresearchcommunity

for

Search:↓

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

New regenerative therapies show promise for treating hair loss.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

PRP helps tissue repair but lacks standard preparation methods.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Costunolide helps human hair cells grow and can stimulate hair growth in mice.

Facial gender surgery techniques focus on forehead and hairline changes for accurate results.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Minoxidil can cause unwanted hair growth, so personalized care and support are important.

Omega-6 fats in certain cells boost male hormone production.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.